Company reportsPresentationsAnnouncementsCurrently selectedAnnual General MeetingFinancial calendarCorporate governanceData of sharesConferences, roadshowsAnalystsContact Announcements Richter signed a licensing agreement with Pharmanest to commercialize its proprietary pain relief product for gynaecological use in certain territories10/12/17Composition of share capital and voting rights 10/02/17Extraordinary announcement10/02/17Mr Erik Bogsch continues as Chairman of the Board of Directors while Mr Gabor Orban becomes CEO effective 1 November 2017Composition of share capital and voting rights 09/01/17Extraordinary announcement08/01/17 Archive
Richter signed a licensing agreement with Pharmanest to commercialize its proprietary pain relief product for gynaecological use in certain territories10/12/17
Extraordinary announcement10/02/17Mr Erik Bogsch continues as Chairman of the Board of Directors while Mr Gabor Orban becomes CEO effective 1 November 2017
